Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

ibalizumab MeSH Supplementary Concept Data 2026


MeSH Supplementary
ibalizumab
Unique ID
C481504
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C481504
Entry Term(s)
Hu-5A8
TMB-355
TNX-355
Trogarzo
ibalizumab-uiyk
Pharm Action
Anti-HIV Agents
Registry Numbers
LT369U66CE
Heading Mapped to
*Antibodies, Monoclonal
Frequency
52
Note
prevents entry of human immunodeficiency virus (HIV) into the host cell. TNX-355 binds to the CD4 receptor on the cell's surface, an entry gate for infection, preventing viral entry and thereby blocking infection.
Source
AIDS Patient Care STDS. 2003 Dec;17(12):655
Indexing Information
HIV Fusion Inhibitors
Date Introduced
2004/02/13
Last Updated
2020/02/28
ibalizumab Preferred
Hu-5A8 Narrower
TMB-355 Narrower
TNX-355 Narrower
Trogarzo Narrower
ibalizumab-uiyk Related
page delivered in 0.006s